FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to phthisiology, and may be used for treating patients with pulmonary tuberculosis. That is ensured by the extracorporeal blood cell treatment by one of anti-tuberculosis preparations and the infusion of a cell suspension of the preparation to the patient. If observing a severe state of the patient, donor's blood cells are treated and introduced into the patient once the state improved. The extracorporeal drug treatment is multiple and combined with common methods of introducing the preparations on the other days between the infusion of the cell suspension with underlying the anti-tuberculosis therapy.
EFFECT: method provides higher clinical effectiveness and reducing death rate in the patients with severe, advanced, acutely progressive forms of tuberculosis with multiple drug resistance of mycobacteria and a severe accompanying pathology.
3 ex
Title | Year | Author | Number |
---|---|---|---|
AUTOLOGOUS COMPOSITION AND METHOD FOR TREATING PULMONARY TUBERCULOSIS WITH DRUG RESISTANCE OF THE PATHOGEN AND ABSENCE OF EFFECT AGAINST THE BACKGROUND OF POLYCHEMOTHERAPY | 2020 |
|
RU2771843C2 |
METHOD OF PULMONARY TUBERCULOSIS TREATMENT | 2006 |
|
RU2329803C1 |
METHOD OF TREATMENT OF PULMONARY TUBERCULOSIS | 2007 |
|
RU2323739C1 |
PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
METHOD OF TREATING PULMONARY TUBERCULOSIS IN HIV-INFECTION PATIENTS | 2008 |
|
RU2383342C1 |
METHOD OF TREATING INFILTRATIVE PULMONARY TUBERCULOSIS INDUCED BY MULTIPLE-DRUG-RESISTANT AND HIGHLY TOXIC STRAINS OF MYCOBACTERIA TUBERCULOSIS | 2009 |
|
RU2423129C1 |
METHOD FOR PREDICTING THE SURVIVAL PERIOD OF PATIENTS WITH THE CLINICAL COURSE OF HIV AND TUBERCULOSIS COINFECTION, ACCOMPANIED BY MULTIDRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS | 2021 |
|
RU2764830C1 |
METHOD FOR DETERMINING THE DURATION OF AN INTENSIVE PHASE OF CHEMOTHERAPY OF RESPIRATORY TUBERCULOSIS IN CHILDREN WITHOUT BACTERIAL RELEASE AND WITHOUT A RISK OF MULTIPLE AND BROAD DRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2020 |
|
RU2737337C1 |
METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2006 |
|
RU2302251C1 |
METHOD FOR PREPARING ANTI-TUBERCULOSIS DRUG | 2010 |
|
RU2452498C2 |
Authors
Dates
2012-10-20—Published
2010-06-11—Filed